The investment in Fujifilm Diosynth Biotechnologies will expand production lines for bulk drug substances and cultivate cells for producing viral vaccines, Fujifilm announced on Tuesday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback